We hypothesized that the characterization of transcripts regulated by SA in somatotroph adenomas with high and low E-cadherin expression may identify signaling pathways and mediators that can explain the poor response to SA treatment. This evidence concerns the gene CDH1 and growth hormone secreting pituitary adenoma 1.